Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Amortization of Deferred Charges of $452000.0 for Q4 2025, up 4.15% year-over-year from $434000.0 in Q4 2024, and up 1.12% quarter-over-quarter from $447000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Amortization of Deferred Charges history runs 16 years deep, the most recent figure standing at $452000.0 for Q4 2025.
- In Q4 2025, Amortization of Deferred Charges rose 4.15% year-over-year to $452000.0; the TTM figure through Dec 2025 stood at $1.8 million (down 37.14% YoY), while the FY2025 annual figure was $1.8 million, down 66.53% from the prior year.
- Amortization of Deferred Charges for Q4 2025 stood at $452000.0, up from $447000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.8 million in Q1 2023, with the low at $428000.0 in Q3 2024.
- The 5-year median for Amortization of Deferred Charges is $821500.0 (2022), against an average of $916950.0.
- The sharpest annual moves came in 2021 and 2025: Amortization of Deferred Charges jumped 111.37% in 2021, then sank 71.07% in 2025.
- Prestige Consumer Healthcare's Amortization of Deferred Charges stood at $1.4 million in 2021, then tumbled by 40.77% to $815000.0 in 2022, then jumped by 74.72% to $1.4 million in 2023, then plunged by 69.52% to $434000.0 in 2024, then advanced by 4.15% to $452000.0 in 2025.
- Business Quant data shows PBH's Amortization of Deferred Charges at $452000.0 in Q4 2025, $447000.0 in Q3 2025, and $442000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 452,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | 447,000.00 |
| Sep 30, 2025 | 447,000.00 |
| Jun 30, 2025 | 442,000.00 |
| Jun 30, 2025 | 442,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Mar 31, 2025 | 438,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.32 Mn |